Clinical Trial Update: Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

View source ↗

Summary

A completed clinical trial at Charles University evaluated biliverdin reductase A in people with chronic hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Hepatitis C, Chronic | Status: COMPLETED